Bioverativ Inc.
DelistedCIK 1681689fmd_0F94M1JSRB237V072VW37HMJMPManufacturing · Pharmaceutical PreparationsTemplate: Standard
Coverage: Jan 01, 2015 to Dec 31, 2017, 9 periods
| Line item | FY2015 | FY2016 | FY2017 |
|---|---|---|---|
| Total revenues | 560 | 887 | 1,169 |
| Cost of revenue | 53 | 238 | 280 |
| Gross profit | 507 | 650 | 889 |
| Research and development | 237 | 210 | 225 |
| Selling, general and administrative | 173 | 147 | 217 |
| Operating income | 98 | 292 | 447 |
| Other non-operating income (expense) | 1 | (1) | 5 |
| Income before taxes | 99 | 292 | 452 |
| Income tax expense | (10) | (148) | 96 |
| Net income from continuing operations | 109 | 440 | 356 |
| Net income | 109 | 440 | 356 |